Bank of New York Mellon Corp
BankPosition in FDMT — 4D Molecular Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in FDMT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,026,080
+$782,201 QoQ
Shares Held
152,337
+14.0% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 158 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,844,507,720 across 311 Biotechnology names. FDMT ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in FDMT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,026,080 | 152,337 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,243,879 | 133,607 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,025,540 | 136,739 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,231,510 | 141,716 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $523,478 | 141,100 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $435,560 | 134,849 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $812,890 | 145,941 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,582,637 | 146,405 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,555,978 | 169,413 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $4,186,339 | 131,398 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,936,484 | 144,940 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,727,599 | 135,711 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,101,124 | 116,277 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,864,341 | 108,455 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,441,100 | 109,910 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $862,023 | 107,217 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $682,692 | 97,807 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,531,988 | 101,322 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,198,080 | 100,186 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,866,808 | 69,218 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $689,554 | 28,636 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $885,689 | 20,417 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||